Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11907517.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methotrexate is beneficial in rheumatoid arthritis and has been used in small studies of patients with systemic lupus erythematosus. We describe a patient with severe subacute cutaneous lupus erythematosus refractory to therapy with antimalarials and corticosteroids. Treatment with methotrexate resulted in complete clearing of the skin lesions without any side effects.
Medical subject headings
- Dermatologic Agents
- Lupus Erythematosus, Cutaneous
- Methotrexate